Vitamin D

Hypovitaminosis D in hypertension.
[20622734] South Med J 103(8): 723-4 (2010)

Effects of vitamin D supplementation on blood pressure.
[20622727] South Med J 103(8): 729-37 (2010)

1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
[19232159] Dan Med Bull 55(4): 186-210 (2008)

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.
[17846391] Arch Intern Med 167(16): 1730-7 (2007)

SOLAR ultraviolet radiation and vitamin D: a historical perspective.
[17761571] Am J Public Health 97(10): 1746-54 (2007)

Vitamin D and cardiovascular prevention.
[20553279] Cardiovasc Ther 28(4): e5-12 (2010)

The complex role of vitamin D in autoimmune diseases.
[18510590] Scand J Immunol 68(3): 261-9 (2008)

Overview of general physiologic features and functions of vitamin D.
[15585789] Am J Clin Nutr 80(6 Suppl): 1689S-96S (2004)

Long-latency deficiency disease: insights from calcium and vitamin D.
[14594776] Am J Clin Nutr 78(5): 912-9 (2003)

The mechanism of action of vitamin D in the intestine.
[158978] Am J Clin Nutr 32(11): 2322-8 (1979)

Vitamin D, its metabolites and analogs: a review of the structural requirements for biological activity.
[187054] Am J Clin Nutr 29(11): 1271-82 (1976)

1,25(OH)2D3-regulated human keratinocyte proliferation and differentiation: basic studies and their clinical application.
[7782932] J Nutr 125(6 Suppl): 1709S-1714S (1995)

Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.
[7782931] J Nutr 125(6 Suppl): 1704S-1708S (1995)

Nongenomic effects of 1,25-dihydroxyvitamin D3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick.
[7782929] J Nutr 125(6 Suppl): 1695S-1698S (1995)

Genomic actions of 1,25-dihydroxyvitamin D3.
[7782928] J Nutr 125(6 Suppl): 1690S-1694S (1995)

Pleiotropic Actions of 1 alpha, 25-dihydroxyvitamin D3: an overview.
[7782927] J Nutr 125(6 Suppl): 1687S-1689S (1995)

The use and interpretation of assays for vitamin D and its metabolites.
[2243289] J Nutr 120 Suppl 11(-): 1464-9 (1990)

Vitamin D and the cardiovascular system.
[19696220] Clin J Am Soc Nephrol 4(9): 1515-22 (2009)

Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease.
[19661219] Clin J Am Soc Nephrol 4(9): 1529-39 (2009)

Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives.
[19056615] Clin J Am Soc Nephrol 4(1): 234-41 (2009)

Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
[20133492] Clin J Am Soc Nephrol 5(3): 512-8 (2010)

Vitamin D metabolism and its clinical application.
[6754741] J Bone Joint Surg Br 64(5): 542-60 (1982)

Promise of vitamin D analogues in the treatment of hyperproliferative conditions.
[16648549] Mol Cancer Ther 5(4): 797-808 (2006)

Calcitriol in cancer treatment: from the lab to the clinic.
[15026558] Mol Cancer Ther 3(3): 373-81 (2004)

Current understanding of the molecular actions of vitamin D.
[9790574] Physiol Rev 78(4): 1193-231 (1998)

Vitamin D and human health: lessons from vitamin D receptor null mice.
[18694980] Endocr Rev 29(6): 726-76 (2008)

Noncalcemic actions of vitamin D receptor ligands.
[15798098] Endocr Rev 26(5): 662-87 (2005)

Meta-analysis: vitamin D compounds in chronic kidney disease.
[18087055] Ann Intern Med 147(12): 840-53 (2007)

Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas.
[8364192] Blood 82(5): 1383-94 (1993)

Vitamin D, osteoclastogenesis and bone resorption: from mechanistic insight to the development of new analogs.
[16960400] Endocr J 54(1): 1-6 (2007)

24,25-Dihydroxyvitamin D--active metabolite or inactive catabolite?
[9681484] Endocrinology 139(8): 3371-4 (1998)

Nonclassic actions of vitamin D.
[18854395] J Clin Endocrinol Metab 94(1): 26-34 (2009)

Resurrection of vitamin D deficiency and rickets.
[16886050] J Clin Invest 116(8): 2062-72 (2006)

Vitamin D-endocrine system.
[2991334] J Clin Invest 76(1): 1-6 (1985)

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
[9379138] J Endocrinol 154 Suppl(-): S57-73 (1997)

Recent progress in enzymology and molecular biology of enzymes involved in vitamin D metabolism.
[7595086] J Lipid Res 36(8): 1641-52 (1995)

1alpha-Hydroxylase and the action of vitamin D.
[11013342] J Mol Endocrinol 25(2): 141-8 (2000)

Update on vitamin D and its newer analogues: actions and rationale for treatment in chronic renal failure.
[12109997] Kidney Int 62(2): 367-74 (2002)

Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure.
[10432376] Kidney Int 56(2): 383-92 (1999)

Vitamin D analogues: how do they differ and what is their clinical role?
[11572878] Nephrol Dial Transplant 16(10): 1965-7 (2001)

What's new in vitamin D for the nephrologist?
[10727539] Nephrol Dial Transplant 15(4): 460-6 (2000)

Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
[11073270] Nephrol Dial Transplant 15 Suppl 5(-): 18-24 (2000)

Importance of vitamin D repletion in uraemia.
[10328449] Nephrol Dial Transplant 14(4): 819-23 (1999)

Vitamin D deficiency in children and its management: review of current knowledge and recommendations.
[18676559] Pediatrics 122(2): 398-417 (2008)

Vitamin D deficient states. Pathophysiology and treatment.
[388869] West J Med 131(4): 305-12 (1979)

Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.
[4365934] West J Med 121(1): 22-44 (1974)

The biological action of calcitriol in renal failure.
[7996783] Kidney Int 46(3): 605-12 (1994)

Vitamin D and calcium transport.
[1662321] Kidney Int 40(6): 1177-89 (1991)

The metabolism and mechanism of action of 1,25-dihydroxyvitamin D3.
[3029498] Kidney Int 30(6): 793-803 (1986)

Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
[4364427] Kidney Int 4(2): 161-7 (1973)

Editorial: Vitamin D, the kidney and calcium homeostasis.
[4365818] Kidney Int 2(5): 241-6 (1972)

Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review).
[11172626] Int J Mol Med 7(2): 201-9 (2001)

The physiology of vitamin D : current concepts.
[18497440] Indian J Med Res 127(3): 256-62 (2008)

Factors influencing vitamin D status.
[21384086] Acta Derm Venereol 91(2): 115-24 (2011)

Vitamin D status: measurement, interpretation, and clinical application.
[18329892] Ann Epidemiol 19(2): 73-8 (2009)

Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy.
[21155624] Altern Med Rev 15(3): 199-222 (2010)

The complexities of vitamin D.
[20439558] Cleve Clin J Med 77(5): 288 (2010)

Prevention of rickets and vitamin D deficiency in infants, children, and adolescents.
[18977996] Pediatrics 122(5): 1142-52 (2008)

Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic.
[19255004] Pediatrics 123(3): 791-6 (2009)

Vitamin D deficiency in adults: when to test and how to treat.
[20675513] Mayo Clin Proc 85(8): 752-7; quiz 757-8 (2010)

High prevalence of vitamin D inadequacy and implications for health.
[16529140] Mayo Clin Proc 81(3): 353-73 (2006)

Vitamin D and hypertension: current evidence and future directions.
[20937970] Hypertension 56(5): 774-9 (2010)

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
[19028748] Nephrol Dial Transplant 24(3): 963-72 (2009)

Association of oral calcitriol with improved survival in non-dialysed and dialysed patients with CKD.
[18997163] Nephrol Dial Transplant 24(2): 341-4 (2009)

Mortality reduction by vitamin D receptor activation in end-stage renal disease: a commentary on the robustness of current data.
[18768581] Nephrol Dial Transplant 24(3): 703-6 (2009)

Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership.
[18400819] Nephrol Dial Transplant 23(6): 1786-9; discussion 1789-3 (2008)

Vitamin D insufficiency, deficiency, and bone health.
[20525913] J Clin Endocrinol Metab 95(6): 2630-3 (2010)

Genetic disorders and defects in vitamin d action.
[20511055] Endocrinol Metab Clin North Am 39(2): 333-46, table of contents (2010)

Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment.
[20511051] Endocrinol Metab Clin North Am 39(2): 271-86, table of contents (2010)

Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.
[19491064] Endocr Pract 15(5): 438-49 (2009)

Cholecalciferol loading dose guideline for vitamin D-deficient adults.
[20139241] Eur J Endocrinol 162(4): 805-11 (2010)

Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection.
[21524386] Discov Med 11(59): 325-35 (2011)

Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.
[19371337] Br J Pharmacol 158(2): 395-412 (2009)

Regulation of renin expression and blood pressure by vitamin D(3).
[12122105] J Clin Invest 110(2): 155-6 (2002)

Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?
[18056830] FASEB J 22(4): 982-1001 (2008)

The role of vitamin D in regulating immune responses.
[20684184] Isr Med Assoc J 12(3): 174-5 (2010)

Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act.
[19164701] Am J Respir Crit Care Med 179(8): 630-6 (2009)

Evidence-based non-skeletal actions of vitamin D.
[20485898] Arq Bras Endocrinol Metabol 54(2): 110-7 (2010)

Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
[21443793] Crit Care 15(2): R104 (2011)

The vitamin D-antimicrobial peptide pathway and its role in protection against infection.
[19895218] Future Microbiol 4(9): 1151-65 (2009)

Role of vitamin D in cardiovascular disease.
[20308705] Neth J Med 68(3): 113-8 (2010)

Vitamin D and the intracrinology of innate immunity.
[20156523] Mol Cell Endocrinol 321(2): 103-11 (2010)

Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
[20798257] Clin J Am Soc Nephrol 5(9): 1717-22 (2010)

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
[20507957] Clin J Am Soc Nephrol 5(9): 1710-6 (2010)

Survival benefits with vitamin D receptor activation: new insights since 2003.
[20507950] Clin J Am Soc Nephrol 5(9): 1704-9 (2010)

Vitamin effects on the immune system: vitamins A and D take centre stage.
[19172691] Nat Rev Immunol 8(9): 685-98 (2008)

Role of vitamin D in chronic kidney disease.
[19371802] Semin Nephrol 29(2): 113-21 (2009)

Factors that influence the cutaneous synthesis and dietary sources of vitamin D.
[17254541] Arch Biochem Biophys 460(2): 213-7 (2007)

An architectural perspective of vitamin D responsiveness.
[17288986] Arch Biochem Biophys 460(2): 293-9 (2007)

Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation.
[17367745] Arch Biochem Biophys 460(2): 218-26 (2007)

Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.
[11914182] Endocr Relat Cancer 9(1): 45-59 (2002)

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
[19926709] Endocr Relat Cancer 17(1): R19-38 (2010)

1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.
[19667238] Circulation 120(8): 687-98 (2009)

Vitamin D: newly discovered actions require reconsideration of physiologic requirements.
[20149679] Trends Endocrinol Metab 21(6): 375-84 (2010)

Human duodenum responses to vitamin D metabolites of TRPV6 and other genes involved in calcium absorption.
[19779013] Am J Physiol Gastrointest Liver Physiol 297(6): G1193-7 (2009)

Vitamin D-inducible calcium transport and gene expression in three Caco-2 cell lines.
[12181175] Am J Physiol Gastrointest Liver Physiol 283(3): G618-25 (2002)

The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes.
[19423758] Endocrinology 150(8): 3448-56 (2009)

Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5 activity.
[16380433] J Am Soc Nephrol 17(1): 26-30 (2006)

Hypervitaminosis D mediates compensatory Ca2+ hyperabsorption in TRPV5 knockout mice.
[16148038] J Am Soc Nephrol 16(11): 3188-95 (2005)

Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney.
[14569082] J Am Soc Nephrol 14(11): 2731-40 (2003)

Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo.
[17556365] J Biol Chem 282(31): 22344-52 (2007)

Mechanisms involved in vitamin D mediated intestinal calcium absorption and in non-classical actions of vitamin D.
[20214989] J Steroid Biochem Mol Biol 121(1-2): 183-7 (2010)

Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor.
[17223545] J Steroid Biochem Mol Biol 103(3-5): 389-95 (2007)

Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes.
[16002434] Mol Endocrinol 19(11): 2685-95 (2005)

Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D(3)-enhanced duodenal calcium transport in male mice.
[22275752] Am J Physiol Endocrinol Metab 302(8): E903-13 (2012)

Vitamin D: molecular mechanism of action.
[18083936] Ann N Y Acad Sci 1116(): 340-8 (2007)

Molecular Mechanisms of Vitamin D Action.
[22782502] Calcif Tissue Int (): (2012)

The vitamin D analog 1alpha,25-Dihydroxy-2beta-(3-Hydroxypropyloxy) vitamin D(3) (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism.
[21912832] Calcif Tissue Int 89(5): 372-8 (2011)

1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells.
[18651709] Eur J Immunol 38(8): 2210-8 (2008)

New insights into the mechanisms of vitamin D action.
[12577303] J Cell Biochem 88(4): 695-705 (2003)

Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
[17924616] J Med Chem 50(23): 5824-32 (2007)

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
[17293108] J Steroid Biochem Mol Biol 103(3-5): 381-8 (2007)

The effects of Vitamin D metabolites on expression of genes for calcium transporters in human duodenum.
[17204416] J Steroid Biochem Mol Biol 103(3-5): 509-12 (2007)

Differential effects of Vitamin D analogs on calcium transport.
[17046242] J Steroid Biochem Mol Biol 103(1): 84-9 (2007)

Effects of vitamin D compounds on renal and intestinal Ca2+ transport proteins in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice.
[15327402] Kidney Int 66(3): 1082-9 (2004)

TRPV6 determines the effect of vitamin D3 on prostate cancer cell growth.
[21347289] PLoS One 6(2): e16856 (2011)

Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport.
[12032488] J Lab Clin Med 139(5): 279-84 (2002)

Vitamin D: an evidence-based review.
[19897699] J Am Board Fam Med 22(6): 698-706 (2009)

The importance of vitamin D levels in autoimmune diseases.
[21125142] Rev Bras Reumatol 50(1): 67-80 (2010)

Benefit-risk assessment of vitamin D supplementation.
[19957164] Osteoporos Int 21(7): 1121-32 (2010)

Vitamin D and non-Hodgkin lymphoma risk in adults: a review.
[19832043] Cancer Invest 27(9): 942-51 (2009)

Optimal use of vitamin D when treating osteoporosis.
[21113692] Curr Osteoporos Rep 9(1): 36-42 (2011)

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity.
[18212810] Nat Clin Pract Endocrinol Metab 4(2): 80-90 (2008)

Vitamin D analogs as anabolic agents.
[17185815] J Musculoskelet Neuronal Interact 6(4): 341-3 (2006)

Vitamin D: clinical measurement and use.
[17185814] J Musculoskelet Neuronal Interact 6(4): 338-40 (2006)

Molecular regulation of calcium and bone metabolism through the vitamin D receptor.
[17185813] J Musculoskelet Neuronal Interact 6(4): 336-7 (2006)

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.
[11743608] Braz J Med Biol Res 35(1): 1-9 (2002)

The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.
[18801384] Mol Aspects Med 29(6): 361-8 (2008)

Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity.
[20119827] J Mol Med (Berl) 88(5): 441-50 (2010)

Childhood asthma may be a consequence of vitamin D deficiency.
[19365260] Curr Opin Allergy Clin Immunol 9(3): 202-7 (2009)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vitamin D.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Vitamin D.php on line 92